54 Biggest Movers From Yesterday
Gainers
Digital World Acquisition Corp. (NASDAQ: DWAC) shares climbed 356.8% to close at $45.50 on Thursday following an announcement the company will merge with Trump Media & Technology Group.
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 16)
Treace Medical Concepts Q2 EPS $(0.10) Beats $(0.12) Estimate, Sales $20.70M Beat $18.93M Estimate
Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 16.67 percent. The company reported quarterly sales of $20.70 million which
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune’s Readout
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 2)
Earnings Scheduled For May 25, 2021
Companies Reporting Before The Bell
• Elbit Systems (NASDAQ:ESLT) is likely to report quarterly earnings at $1.40 per share on revenue of $1.10 billion.
JP Morgan Initiates Coverage On Treace Medical Concepts with Overweight Rating, Announces Price Target of $37
JP Morgan analyst Robbie Marcus initiates coverage on Treace Medical Concepts (NASDAQ:TMCI) with a Overweight rating and announces Price Target of $37.
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-the-board weakness in markets, as macroeconomic fears unnerved traders.